Global Blood Therapeutics, Inc.
GBT
Price:
$68.49
Market Cap:
$0
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemogl...[Read more]
Industry
Biotechnology
IPO Date
2015-08-12
Stock Exchange
NASDAQ
Ticker
GBT
The PE Ratio as of July 2024 (TTM) for Global Blood Therapeutics, Inc. (GBT) is -14.08
According to Global Blood Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -14.08. This represents a change of 134.16% compared to the average of -6.01 of the last 4 quarters.
Global Blood Therapeutics, Inc. (GBT) Historical PE Ratio (quarterly & annually)
How has GBT PE Ratio performed in the past?
The mean historical PE Ratio of Global Blood Therapeutics, Inc. over the last ten years is -17.29. The current -14.08 PE Ratio has changed 8.04% with respect to the historical average. Over the past ten years (40 quarters), GBT's PE Ratio was at its highest in in the December 2016 quarter at -4.86. The PE Ratio was at its lowest in in the March 2014 quarter at -46.00.
Average
-17.29
Median
-12.05
Minimum
-51.88
Maximum
-5.82
Global Blood Therapeutics, Inc. (GBT) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Global Blood Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 144.59%
Maximum Annual PE Ratio = -5.82
Minimum Annual Increase = -68.68%
Minimum Annual PE Ratio = -51.88
| Year | PE Ratio | Change |
|---|---|---|
| 2021 | -6.08 | -43.37% |
| 2020 | -10.73 | -38.25% |
| 2019 | -17.38 | 44.17% |
| 2018 | -12.05 | -15.30% |
| 2017 | -14.23 | 144.59% |
| 2016 | -5.82 | -34.85% |
| 2015 | -8.93 | -68.68% |
| 2014 | -28.51 | -45.04% |
Global Blood Therapeutics, Inc. (GBT) Average PE Ratio
How has GBT PE Ratio performed in the past?
The current PE Ratio of Global Blood Therapeutics, Inc. (GBT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.40
5-year avg
-12.09
10-year avg
-17.29
Global Blood Therapeutics, Inc. (GBT) PE Ratio vs. Peers
How is GBT’s PE Ratio compared to its peers?
Global Blood Therapeutics, Inc.’s PE Ratio is
| Company | PE Ratio | Market cap |
|---|
Build a custom stock screener for Global Blood Therapeutics, Inc. (GBT) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Global Blood Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Global Blood Therapeutics, Inc. (GBT) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Global Blood Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Global Blood Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Global Blood Therapeutics, Inc. (GBT)?
What is the highest PE Ratio for Global Blood Therapeutics, Inc. (GBT)?
What is the 3-year average PE Ratio for Global Blood Therapeutics, Inc. (GBT)?
What is the 5-year average PE Ratio for Global Blood Therapeutics, Inc. (GBT)?
How does the current PE Ratio for Global Blood Therapeutics, Inc. (GBT) compare to its historical average?